Risked-based Monitoring Blog

Jun 2019

DIA 2019 Global Annual Meeting – San Diego

By |2019-04-01T08:01:29+00:00June 23, 2019||Comments Off on DIA 2019 Global Annual Meeting – San Diego

We are pleased to announce that, on behalf of the DIA 2019 Annual Meeting Program Committee, our abstract titled: "Main Difference between Quality Tolerance Limits and Key Risk Indicators" has been accepted for a poster presentation at DIA 2019 in San Diego!

May 2019

Centralized Monitoring: a Greater Advantage to a Broader Range of Trials

By |2019-05-07T09:37:52+00:00May 2, 2019|Blog, Infographic|0 Comments

Regulatory bodies are unanimous, today's clinical research needs Centralized Monitoring. We summarized Centralized Monitoring the infographic way, download your free copy here...

Apr 2019

FDA Q&A Draft Guidance Document: The RBM Process-Technology Fit

By |2019-05-27T15:16:11+00:00April 15, 2019|Blog|0 Comments

Our expert team reviewed the March 2019 RBM Q&A draft guidance document and extended the FDA guidance with RBM solution specific insights and a MindMap to help you even further.

Apr 2019

RBM Software Features: What’s a Risk Flower chart?

By |2019-04-09T12:43:18+00:00April 9, 2019|Blog, Neat Features|1 Comment

Neat Features: wanting to dig a little deeper into the neat software features that make your risk-management life easy? Well, you’ve come to the right place. Learn more about Risk Flowers charts - a bunch of information.

Mar 2019

Your Practical Guide to Understanding Clinical KRIs

By |2019-03-20T10:55:19+00:00March 12, 2019|Infographic, News|0 Comments

Our key risk indicator infographic will give you a foundational understanding of KRIs, provide valuable examples of KRIs, and guide you towards getting started with your risk-based monitoring (RBM) program.

Mar 2019

15. DVMD-Fachtagung in Düsseldorf

By |2019-03-04T07:31:03+00:00March 5, 2019||Comments Off on 15. DVMD-Fachtagung in Düsseldorf

Die Fachtagungen des DVMD sind jedes Mal ein informativer Querschnitt aus allen relevanten Themen rund um Dokumentation und Informationsmanagement in der Medizin. Jede Fachtagung greift dabei immer ein Schwerpunktthema auf. In 2019 wird es der Einfluss der Digitalisierung auf die Medizin sein.

Feb 2019

3 Critical Aspects of Clinical Trial Conduct that Affect the Totality of Evidence

By |2019-02-27T20:13:40+00:00February 27, 2019|Blog|0 Comments

Even without it being mandated, health authorities typically expect pharma and biotech companies to conduct two well-controlled Phase 3 trials demonstrating efficacy and safety. Still today this principle ensues discussions regarding the quantity and quality of the evidence needed to establish effectiveness.

Feb 2019

DIA Europe 2019

By |2019-01-23T10:11:05+00:00February 5, 2019|Comments Off on DIA Europe 2019

DIA Europe is more than a traditional meeting. It's a chance to learn, engage, and grow as a healthcare professional alongside thousands of cross-functional collaborative leaders. Our CEO, Dr Artem Andrianov, will share his industry insights and expertise as one of the selected speakers. We hope your busy schedule will allow you to meet with Artem.

Upcoming Events

Register Today!

Get Free Test Access